 |
 |

Evoked Potentials in Cerebrotendinous Xanthomatosis and Effect Induced by Chenodeoxycholic Acid
Mauro Mondelli, MD;
Alessandro Rossi, MD;
Chiara Scarpini, MD;
Maria Teresa Dotti, MD;
Antonio Federico, MD
Arch Neurol. 1992;49(5):469-475.
Abstract
Evoked potentials are reported in 10 patients with cerebrotendinous xanthomatosis, eight of whom had peripheral neuropathy. Four subjects showed delayed N13 to N20 interpeak latencies for arm somatosensory evoked potentials, and five showed moderately prolonged I to III and I to V interpeak latencies of brain-stem auditory evoked potentials. Six of seven patients showed marked delay and desynchronization of visual evoked potentials. All five patients undergoing transcutaneous magnetic stimulation of the motor cortex presented greatly delayed central motor conduction time, especially of the lower limbs. After treatment with chenodiol (750 mg/d for at least 2 years), there was a significant improvement in nerve conduction velocities, N13 to N20 interpeak latencies, and visual evoked potential latencies. Brain-stem auditory evoked potentials remained unchanged.
Author Affiliations
From the Institute of Neurological Sciences, Medical School, University of Siena, Italy.
Footnotes
Accepted for publication December 6, 1991.
Reprint requests to Institute of Neurological Sciences, Viale Bracci, 53100 Siena, Italy (Dr Mondelli).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cerebrotendinous Xanthomatosis: Clinical Manifestations, Diagnostic Criteria, Pathogenesis, and Therapy
Federico and Dotti
J Child Neurol 2003;18:633-638.
ABSTRACT
Cerebrotendinous xanthomatosis
Federico et al.
Neurology 2001;57:1743-1743.
FULL TEXT
Mutations producing premature termination of translation and an amino acid substitution in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis associated with parkinsonism
Wakamatsu et al.
J. Neurol. Neurosurg. Psychiatry 1999;67:195-198.
ABSTRACT
| FULL TEXT
|